| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |